Clinical factors affecting renal response to dulaglutide.

<p>(A) A significantly less decline in eGFR was observed in participants with baseline proteinuria compared with those without. (B, C) The effect of dulaglutide use on eGFR changes was better in relatively young patients (age ≤ 65 years) and in those with HbA1c ≤ 9.0%. (D) However, changes in...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Sungmin Kim (628527) (author)
مؤلفون آخرون:	Jung Nam An (9301900) (author), Young Rim Song (13242926) (author), Sung Gyun Kim (11758004) (author), Hyung Seok Lee (13242929) (author), AJin Cho (4524091) (author), Jwa-Kyung Kim (756295) (author)
منشور في:	2022
الموضوعات:	Medicine Genetics Molecular Biology Marine Biology Cancer Science Policy Infectious Diseases Virology two tertiary hospitals good therapeutic option body mass index 3 ), 31 type 2 diabetes least 3 months chronic kidney disease 5 ), 46 subgroup analysis showed severe ckd treated 4 ), respectively 8 ± 6 5 ± 5 1 ± 3 8 ± 4 renal protective effect mean hba1c level mean egfr change 0 ± 8 xlink "> dulaglutide 2 </ sup xlink "> 4 ), ± 1 – 2 renal function mean egfr mean decrease kidney outcomes ckd 2 6 kg 16 months – 0 weekly dulaglutide similar across reduced decline per year median duration lowering efficacy january 2017 improved cardiovascular december 2020 ckd stage ckd ). >- test 003 ). 0 %,
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Clinical factors affecting renal response to dulaglutide.

مواد مشابهة